• 33.1k views

Cancer Genomics – It’s role in managing Cancers

Cancer genomics plays a pivotal role in the management of cancers by providing comprehensive insights into the genetic alterations underlying tumor development. This field involves analyzing the DNA and genetic makeup of cancer cells, enabling a more personalized and targeted approach to diagnosis and treatment. By understanding the specific genetic mutations driving cancer growth, clinicians can tailor therapies to target these specific abnormalities, leading to more effective and less toxic treatments. Additionally, cancer genomics facilitates the identification of potential biomarkers for early detection and prognosis, ushering in a new era of precision medicine that holds the promise of improved outcomes for cancer patients.

About the Speaker

Dr K.C. Goutham Reddy Profile Image

Dr K.C. Goutham Reddy

Senior Consultant Medical Oncologist, Karkinos Healthcare, Hyderabad

Dr. K.C. Goutham Reddy is an accomplished medical professional with a remarkable educational background and extensive expertise in oncology. He graduated with distinction in MBBS and has made notable contributions to medical research, presenting papers across various disciplines. Dr. Reddy holds specialized qualifications including DNB in Radiation Oncology, FHPRT in High Precision Radiotherapy, DrNB in Medical Oncology, and FPM in Pain Medicine.

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr K.C. Goutham Reddy's Talks on Assimilate

webinar
Dr K.C. Goutham Reddy
  • 4th-December-2023, TIME : 03:00PM - 04:00PM
  • 0

Cancer genomics plays a pivotal role in the management of cancers by providing comprehensive insights into the genetic alterations underlying tumor development. This field involves analyzing the DNA and genetic makeup of cancer cells, enabling a more personalized and targeted approach to diagnosis and treatment. By understanding the specific genetic mutations driving cancer growth, clinicians can tailor therapies to target these specific abnormalities, leading to more effective and less toxic treatments. Additionally, cancer genomics facilitates the identification of potential biomarkers for early detection and prognosis, ushering in a new era of precision medicine that holds the promise of improved outcomes for cancer patients.